Chronic heart failure in Japan: Implications of the CHART studies

Vascular Health and Risk Management

Volumn 4, Issue 1, 2008, Pages 103-113

  Shiba, Nobuyuki ^a   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Aging; Heart failure; Japanese

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; AZOSEMIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CANDESARTAN; CARVEDILOL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; OLMESARTAN; PITAVASTATIN; PLACEBO; VALSARTAN;

AGING; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DIABETES MELLITUS; DRUG DOSE COMPARISON; DRUG EFFICACY; ECHOCARDIOGRAPHY; GASTROENTERITIS; HEALTH INSURANCE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; JAPAN; MEDICAL CARE; OPTIMAL DRUG DOSE; PNEUMONIA; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; QUALITY OF LIFE; RACE DIFFERENCE; REVIEW; SOCIAL STATUS; TREATMENT OUTCOME; TUBERCULOSIS;

ADRENERGIC BETA-ANTAGONISTS; AGING; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CAUSE OF DEATH; CHRONIC DISEASE; CLINICAL TRIALS AS TOPIC; HEART FAILURE; HUMANS; INSURANCE, HEALTH; JAPAN; PREVALENCE; PROGNOSIS; REGISTRIES; RISK FACTORS;

EID: 41549121043     PISSN: 11766344     EISSN: None     Source Type: Journal    
DOI: 10.2147/vhrm.2008.04.01.103     Document Type: Review

References (31)

1. Bansal D, Chahoud G, Smith ES, et al. 2006. Prevention of heart failure. Curr Opin Cardiol, 21:510-16.
2. Benfante R. 1992. Studies of cardiovascular disease and cause-specific mortality trends in Japanese-American men living in Hawaii and risk factor comparisons with other Japanese populations in the Pacific region: a review. Hum Biol, 64:791-805.
3. Bettencourt P, Ferreira A, Dias P, et al. 2000. Predictors of prognosis in patients with stable mild to moderate heart failure. J Card Fail, 6:306-13.
4. Deedwania PC. 2003. The key to unraveling the mystery of mortality in heart failure: An integrated approach. Circulation, 107:1719-21.
5. Exercise and Physical Activity Reference for Health Promotion 2006. Office for Lifestyle-related Diseases Control, General Affairs Division, Health Service Bureau, Ministry of Health, Labour Welfare [online]. Accessed on June 10, 2007. URL: http://www.nih.go.jp/eiken/english/ research/program_exercise_epar2006.html.
6. Ezekowitz JA, McAlister FA, Armstrong PW, et al. 2003. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation, 107:223-5.
7. Hansson L, Hedner T, Dahlof B. 1992. Prospective randomized open blinded end-point (PROBE) study. A novel design for intervention trials. Blood Press, 1:113-19.
8. Hori M, Sasayama S, Kitabatake A, et al. 2004. Low-dose carvedilol improves left ventricular function and reduces cardiovascular hospitalization in Japanese patients with chronic heart failure: the Multicenter Carvedilol Heart Failure Dose Assessment (MUCHA) trial. Am Heart J, 147:324-30.
9. Hunt SA, Baker DW, Chin MH, et al. 2001. ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary. J Am Coll Cardiol, 38:2101-13.
10. Ito M. 2004. Health Insurance Systems in Japan: a Neurosurgeon's View. Neurol Med Chir (Tokyo), 44:617-28.
11. Kubota T, Yamamura Y, Ohkawa N, et al. 2000. Frequencies of CYP2D6 mutant alleles in a normal Japanese population and metabolic activity of dextromethorphan O-demethylation in different CYP2D6 genotypes. Br J Clin Pharmacol, 50:31-4.
12. Life Expectancies at Specified Ages. Abridged Life Tables For Japan 2006, Ministry of Health, Labour and Welfare [online]. Accessed on June 10, 2007. URL: http://www.mhlw.go.jp/english/database/dbhw/lifetb06/ 1.html.
13. Masoudi FA, Havranek EP, Wolfe P, et al. 2003. Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure. Am Heart J, 146:250-7.
14. Matsumori A, ARCH-J study investigators. 2003. Efficacy and safety of oral candesartan cilexetil in patients with congestive heart failure. Eur J Heart Fail, 5:669-77.
15. Menotti A, Blackburn H, Kromhout D, et al. 2001. Cardiovascular Risk Factors as Determinants of 25-year All-cause Mortality in the Seven Countries Study. Eur J Epidemiol, 17:337-46.
16. Mochizuki S, Dahlöf B, Shimizu M, et al. 2007. Valsartan in a Japanese population with hypertension and other cardiovascular disease (Jikei Heart Study): a randomised, open-label, blinded endpoint morbidity-mortality study. Lancet, 369:1431-9.
17. O'Meara E, Clayton T, McEntegart MB, et al. 2006. Clinical correlates and consequences of anemia in a broad spectrum of patients with heart failure: results of the Candesartan in Heart Failure: Assessment of Reduction in Mortality and Morbidity (CHARM) Program. Circulation, 113:986-94.
18. Ranade K, Jorgenson E, Sheu WHH, et al. 2002. A polymorphism in the beta-1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet, 70:935-42.
19. Rector TS, Cohn JN. 1994. Prognosis in congestive heart failure. Annu Rev Med, 45:341-50.
20. Shiba N, Watanabe J, Shinozaki T, et al. 2004. Analysis of chronic heart failure registry in the Tohoku district: third year follow-up. Circ J, 68:427-34.
21. Shiba N, Watanabe J, Shinozaki T, et al. 2005. Poor prognosis of Japanese patients with chronic heart failure following myocardial infarction comparison with nonischemic cardiomyopathy. Circ J, 69:143-9.
22. Shiba N, Takahashi J, Matsuki M. 2007. The CHART Study (Japanese). Naika, 99:410-14.
23. Summary of Vital Statistics. 2005. Summary of Vital Statistics. Ministry of Health, Labour and Welfare [online]. Accessed on July 6, 2007, URL: http://www.mhlw.go.jp/english/database/db-hw/Populate/index.html.
24. Tada T, Shiba N, Watanabe J, et al. 2007. Prognostic value of anemia in predicting sudden death of patients with diastolic heart failure. Int J Cardiol, In Press.
25. The Status of Aging and Implementation of Measures for Aging Society in FY 2005. Annual Report on the Aging Society 2007, Cabinet Office [online]. Accessed on June 10, 2007. URL: http://www.cao.go.jp/ index-e.html.
26. Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, et al. 2006. Clinical characteristics and outcome of hospitalized patients with heart failure in Japan. -Rationale and design of Japanese Cardiac Registry of Heart Failure in Cardiology (JCARE-CARD)-. Circ J, 70:1617-23.
27. Tsutsui H, Tsuchihashi-Makaya M, Kinugawa S, et al. 2007. Characteristics and outcomes of patients with heart failure in general practices and hospitals. -Japanese Cardiac Registry of Heart Failure in General Practice (JCARE-GENERAL). Circ J, 71:449-54.
28. Van den Hoogen P, Feskens EJM, Nagelkerke NJD, et al. 2000. The Relation between Blood Pressure and Mortality due to Coronary Heart Disease among Men in Different Parts of The World. N Engl J Med, 342:1-8.
29. Watanabe J, Shiba N, Shinozaki T, et al. 2005. Prognostic value of plasma brain natriuretic peptide combined with left ventricular dimensions in predicting sudden death of patients with chronic heart failure. J Card Fail, 11:50-5.
30. Watanabe J, Shinozaki T, Shiba N, et al. 2006. Accumulation of risk markers predicts the incidence of sudden death in patients with chronic heart failure. Eur J Heart Fail, 8:237-42.
31. Xie HG, Kim RB, Wood AJJ, et al. 2001. Molecular basis of ethnic differences in drug disposition and response. Annu Rev Pharmacol Toxicol, 41:815-50.